Effects of a novel purine nucleoside phosphorylase inhibitor, BCX-34, on activation and proliferation of normal human lymphoid cells

Authors: Conry R.M.1; Bantia S.; Turner H.S.; Barlow D.L.; Allen K.O.; LoBuglio A.F.; Montgomery J.A.; Walsh G.M.

Source: Immunopharmacology, Volume 40, Number 1, July 1998 , pp. 1-9(9)

Publisher: Elsevier

Purchase options

This article is hosted on another website.

You may be required to register, activate a subscription or purchase the article before you can obtain the full text.

Proceed

More like this?
Content Key:
Free Content - Free
New Content - New
Open Access Content - Open Access
Subscribed Content - Subscribed
Free Trial Content - Free Trial

Keywords: BCX-34; Purine nucleoside phosphorylase; T-cell; IL-2; Mixed lymphocyte reaction; OKT3; Tetanus toxoid

Language: English

Document Type: Research article

DOI: 10.1016/S0162-3109(98)00012-5

Affiliations: 1: Comprehensive Cancer Center, The University of Alabama at Birmingham, WTI 263, 6th Avenue South, Birmingham, AL 35294-3300, USA

Back to top

Content Key:
Free Content - Free
New Content - New
Open Access Content - Open Access
Subscribed Content - Subscribed
Free Trial Content - Free Trial
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in
Need to register?
Sign up here
Text size: A | A | A | A